Janney Montgomery Scott LLC Purchases 5,753 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH)

2 min read | February 03, 2025 07:25 PM AEDT | By Team Kalkine Media

Janney Montgomery Scott LLC Purchases 5,753 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Institutional Investment Surge

During the fourth quarter, significant changes were observed in the holdings of Lantheus Holdings, Inc. (NASDAQ:LNTH) among institutional investors. Janney Montgomery Scott LLC notably expanded its stake, increasing its holdings by 40.9%. It acquired an additional 5,753 shares, culminating in a total of 19,806 shares worth approximately $1.77 million. This considerable increase signifies a growing confidence in the medical equipment provider.

Broad Institutional Interest

Other prominent investors have also shown an increased interest in Lantheus. Dakota Wealth Management and UMB Bank n.a. augmented their holdings by 13.4% and 31.5%, respectively. Shelton Wealth Management LLC took a substantial position with a 77.8% increase in its holdings. Meanwhile, Procyon Advisors LLC enhanced their portfolio with an 11.1% rise in shares. Notably, Empirical Asset Management LLC acquired new stakes valued at approximately $323,000. Institutional ownership now dominates the shareholder base, with a substantial 99.06% control of the company's stock, reflecting a strong institutional backing.

Stock Performance Overview

Lantheus Holdings opened at $92.51, with a noticeable fluctuation over the past 12 months, ranging from a low of $51.79 to a high of $126.89. The company boasts a market capitalization of $6.43 billion, presenting a price-to-earnings ratio of 15.39 and a beta of 0.46. The stock's performance reflects its market resilience and adaptability amidst changing economic conditions.

Company Profile

Lantheus Holdings, Inc. is renowned for its development and commercialization of diagnostic and therapeutic products. The company offers a diverse product range, including DEFINITY, TechneLite, Xenon-133, Neurolite, Cardiolite, and PYLARIFY. Each product plays a pivotal role in diagnosing and treating various diseases globally, underscoring Lantheus's significant impact in the healthcare industry.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.